2Miyata T, Notoya K, Yoshida K, et al. Advanced glycation end products enhance osteoclast-induced bone resorption in cultured mouse unfractionated bone cells and in rats implanted subcutaneously with devitalized bone panicles[ J]. J Am Soc Nephrol, 1997,8 (2) : 260 - 270.
3Lalla E, Lamster IB, Schmidt AM. Enhanced interaction of advanced glycation end products with their cellular receptor RAGE : Implications for the pathogenesis of accelerated periodontal disease in diabetes [ J ]. Ann Periodontol, 1998,3 (1) :13 -19.
4Vlassara H, Bucala R, Striker L. Pathogenic effects of advanced glycosylation: Biochemical, biologic and clinical implications for diabetes and aging [ J ]. Lab Invest, 1994,70(2) :138 -151.
5Rickard D J, Subramaniam M, Spelsberg TC. Molecular and cellular mechanisms of estrogen action on the skeleton[J]. J Cell Biochem, 1999, Suppl 32 - 33 : 123 - 132.
6Kameda T, Mano H, Yuasa T, et al. Estrogen inhibits bone resorption by directly inducing apoptosis of the bone-resorbing osteoclasts[J]. J Exp Med, 1997, 186(4): 489- 495.
7Ahmed N, Furth AJ. A microassay for protein glycation based on the perriodate method[ J]. Anal Biochem, 1991, 192(1) :109- 111.
